Could Eli Lilly's Zepbound Become the World's Best-Selling Drug?

You may not expect a pharmaceutical stock to mimic the behavior of the latest hot growth stock and soar in the triple digits over 12 months. But Eli Lilly (LLY 0.61%) did it, climbing nearly 117% over the past year. This wasn't just a random happening, but instead evidence investors are very excited about what's to come for this pharma giant.Lilly's portfolio is generating double-digit revenue growth, into the billions of dollars. And the products leading this are two that doctors have been prescribing for ...